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Abstract
Background Previous studies identifying hearing loss as a promising modifiable risk factor for cognitive decline mostly 
adjusted for baseline age solely. As such a faster cognitive decline at a higher age, which is expected considering the non-
linear relationship between cognition and age, may have been overlooked. Therefore it remains uncertain whether effects of 
hearing loss on cognitive decline extend beyond age-related declines of cognitive function.
Methods 3,590 non-demented participants were eligible for analysis at baseline, and a maximum of 837 participants were 
eligible for the longitudinal analysis. Hearing loss was defined at baseline. Cognitive function was measured at baseline and 
at follow-up (4.4 years [SD: 0.2]). Multivariable linear regression analysis was used for the cross-sectional analysis. Linear 
mixed models were used to assess the longitudinal association between hearing loss and cognitive decline over time while 
adjusting for confounders and the interaction of age and follow-up time.
Results Hearing loss was associated with lower cognitive function at baseline. Moreover, hearing loss was associated with 
accelerated cognitive decline over time on a memory test. After additionally adjusting for the interaction between age and 
follow-up time, we found that hearing loss did not accelerate cognitive decline anymore.
Conclusions Hearing loss was associated with lower cognitive function at baseline and accelerated cognitive decline on a 
memory test. The association between hearing loss and accelerated cognitive decline was non-significant after additional 
adjustment for non-linear age effects. More evidence is needed to ensure the role of hearing loss as a modifiable risk factor 
for cognitive decline.
Keywords Hearing loss · Presbycusis · Cognitive decline · Aging · Dementia
Introduction
Recently, hearing loss has been put forward as a promis-
ing modifiable risk factor for cognitive decline and demen-
tia [5, 28, 29, 32, 45]. Both the prevalence of hearing loss 
and dementia will increase substantially due to the aging 
of the worldwide population [2, 15, 32]. With the increas-
ing numbers of both conditions, it is of great importance to 
determine if hearing loss is independently associated with 
cognitive decline in dementia-free participants. As such, 
more can be said on whether hearing rehabilitative treat-
ments may potentially alter or delay the progression of cog-
nitive decline.
Several longitudinal studies reported associations 
between hearing loss and poorer cognitive function [7], and 
with an increased risk of dementia [2, 5, 10, 11, 29, 30, 
50]. Despite these promising results, several methodologi-
cal issues should be considered. First, both hearing loss and 
cognitive impairment are heavily dependent on age, reflected 
in a steep increase of the prevalence of both with increasing 
age [15, 20]. Therefore, it is of importance to adjust for both 
linear and non-linear age effects in the association between 
hearing loss and cognition. To our knowledge, only one 
other study incorporated age non-linearly in their models 
[7]. Yet, it is plausible that older people may decline faster 
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over time on cognitive abilities compared to their younger 
counterparts. Keeping this age-related decline into account 
can be accomplished by adding an interaction between age 
and follow-up time into statistical models. Second, some 
studies rely on a limited battery of neuropsychological tests 
for cognitive assessment [9, 12, 13, 16–18, 28, 30, 31, 33, 
37, 43, 44]. This potentially increases the likelihood of 
misclassification of cognitive impairment [22], especially 
in those with higher levels of hearing impairment. Lower 
scores on cognitive tests may partially be falsely attributed 
to cognitive impairment, as individuals might not be able to 
hear verbal test instructions properly [36, 39]. Third, hear-
ing loss does not necessarily accurately reflect an inability 
to follow speech in noisy environments [34]. To our knowl-
edge, only one other study incorporated a measure of speech 
understanding in their analyses [33].
Against this background, we aimed to elucidate whether 
hearing loss accelerates cognitive decline over time in 
dementia-free participants whom are at risk of cognitive 
decline and cognitive impairment from a large population-
based study. We measured hearing loss, including speech 
understanding, and repeatedly assessed cognitive function-
ing with comprehensive cognitive testing. We examined 
whether trajectories of cognitive decline differed across 
degrees of hearing impairment while adjusting for poten-
tially strong effects of age.
Methods
Study setting and population
This study is embedded in the Rotterdam Study, a prospec-
tive, population-based cohort study. The Rotterdam Study 
was initiated in 1989 and investigates determinants and con-
sequences of aging. Details of the study have been described 
previously [21]. The entire study population consists of 
14,926 individuals aged ≥ 45 years from the Ommoord area, 
a suburb of Rotterdam, the Netherlands, who undergo exten-
sive examinations at the research center at study entry and 
subsequent visits every 3–4 years. In 2011, hearing assess-
ment was introduced into the study protocol. For the present 
study, we sampled two study populations, described in detail 
below.
Hearing loss and cognitive function: cross‑sectional study 
population
In total, 3739 participants underwent baseline hearing assess-
ment (2011–2014). We excluded participants with prob-
able conductive hearing loss (air–bone gap ≥ 15 dB; N = 83), 
participants with a history of dementia or those who were 
insufficiently screened for dementia at baseline (N = 51), 
and participants who developed dementia during follow-
up (N = 15), leaving 3590 participants with baseline hear-
ing assessment. From those 3590 participants, data were 
available on different cognitive tests, namely the MMSE 
(N = 3584), the Stroop test (N = 3500), the Word Fluency test 
(WFT) (N = 3536), the Letter Digit Substitution test (LDST) 
(N = 3507), the Word Learning test (WLT) (N = 3239), and 
the Purdue Pegboard test (PPT) (N = 3264). There were 3498 
participants with both data on hearing thresholds and speech 
understanding in noise.
Hearing loss and cognitive decline: longitudinal study 
population
Data on the different cognitive tests from participants who 
were re-invited for follow-up measurements and with avail-
able cognitive data at baseline, were available at follow-up 
(2015–2016) for the longitudinal analysis. At follow-up, 837 
participants had data available for the MMSE, 764 participants 
for the Stroop test, 519 participants for the WFT, 780 partici-
pants for the LDST, 755 participants for the WLT, and 714 
participants for the PPT. The mean time interval between cog-
nitive baseline assessment and re-examination was 4.4 years 
(SD: 0.2). See supplementary methods for an explanation 
regarding the attrition rate.
Hearing
Hearing thresholds measured with pure‑tone audiometry
To determine hearing loss expressed by hearing thresholds 
in decibel (dB), pure-tone audiometry (PTA) was performed 
in a soundproof booth [21]. A computer-based audiometry 
system (Decos Technology Group, version 210.2.6, Audi-
oNigma interface) and TDH-39 headphones were used. dB 
hearing levels were measured according to the ISO-standard 
8253-1 (International Organization for Standardization, 2010). 
Air conduction (frequencies 0.25–8 kilohertz [kHz]) and bone 
conduction (0.5 and 4 kHz) were tested for both ears while 
masking according to the method of Hood [19]. The best hear-
ing ear was determined by taking the average hearing thresh-
olds over all frequencies and identified by the lowest hear-
ing threshold of one of both ears. Of the best hearing ear, we 
determined the average speech frequencies threshold (average 
of 0.5, 1, 2, and 4 kHz) levels. Finally, we determined degrees 
of hearing loss: normal hearing (0–20 dB), mild hearing loss 
(20–35 dB), moderate hearing loss (35–50 dB), and severe 
hearing loss (≥ 50 dB) [21, 41].
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Speech understanding in noise measured 
with the digits‑in‑noise test
To measure speech understanding in noise, we derived a 
signal-to-noise ratio (SNR; in dB) from the digits-in-noise 
(DIN) test, a 3-min test of speech understanding in noise 
[25]. Both speech and noise signal were presented in the 
participant’s better hearing ear. Pre-recorded male-spoken 
speech-signal consisted of 24 digit triplets. Initially, the tri-
plet was presented at 0 dB SNR. In case of an incorrect 
response, the next triplet was presented more intensely. After 
the first correct response, the speech level was decreased and 
a new stimulus was presented. For a correct response, the 
intensity was decreased again, while an incorrect response 
lead to an increase of the intensity. This was repeated until 
24 triplets were repeated. SNR was the average of the last 
20 triplets. We defined hearing categories based on optimal 
SNR cut points defined by clinically relevant degree of hear-
ing loss using Youden’s Index (Supplementary Fig. 1) [52].
Cognition
Cognitive function was assessed in detail with an extensive 
neuropsychological test battery comprising the MMSE, the 
Stroop test (adjusted interference score; inverted as higher 
scores indicate worse performance), the WFT (amount of 
animals named within 60 s), the LDST (number of correct 
digits within 60 s), the 15-WLT (total number of words 
remembered at least 10 min after immediate recall), and the 
PPT (sum score of three trials). The MMSE was adminis-
tered during a home visit, the other tests were administered 
at the research center. All tests instructions were presented 
verbally. The MMSE is a validated screening tool for cogni-
tive decline and cognitive impairment [46]. The Stroop test 
is a validated test measuring executive functioning, more 
specifically it measures the ability to inhibit cognitive inter-
ference [40]. To accurately and reliably measure verbal flu-
ency, the WFT was used [42]. With the validated LDST, we 
measured executive functioning including processing speed 
and attention [47]. The 15-WLT is a validated test measur-
ing memory functioning [3]. Results of the WLT are not 
negatively influenced by hearing status, as the 15 different 
words are visually presented to the participants. The PPT is 
a validated measure of unilateral and bilateral fine manual 
dexterity [8].
Covariates
During home interviews, educational level was assessed and 
categorized as primary education, lower education, interme-
diate vocational education and higher education. Smoking 
habits were assessed during the same interview and subse-
quently classified into never, former and current smoking 
[21]. Alcohol consumption was assessed through self-report 
with the food-frequency questionnaire [48], and we subse-
quently calculated daily alcohol consumption in grams [48]. 
Systolic and diastolic blood pressures were measured twice 
on the right arm with a random-zero sphygmomanometer; 
the mean of these readings was used for the analyses. Use 
of antihypertensive medication was assessed by interview 
[21]. Participants were screened for dementia at baseline 
and follow-up examinations using a protocol described in 
detail elsewhere [4].
Statistics
We investigated whether baseline characteristics differed 
between participants with just a baseline assessment and 
participants with both a baseline and a follow-up assess-
ment using T tests, χ2 tests, and Mann–Whitney U Tests 
when appropriate. Subsequently, we present three sequential 
analyses to examine the association between hearing loss 
and cognition.
First, we assessed the cross-sectional association between 
hearing loss (all frequencies, speech frequencies, degrees of 
hearing loss and SNR) and cognitive functioning at baseline 
using multivariable linear regression models. We adjusted 
for age,  age2, sex, education, alcohol consumption, smok-
ing behavior, systolic- and diastolic blood pressure, and use 
of blood pressure lowering medication. All SNR analyses 
were additionally adjusted by PTA hearing levels for all 
frequencies.
Second, we used linear mixed models with random inter-
cepts and slopes to elucidate the longitudinal association 
between degrees of hearing loss (mild, moderate or severe 
compared to normal hearing defined by either PTA or SNR) 
and cognitive trajectories per test. In each model, we entered 
follow-up time in years after baseline measurement to use as 
time variable. For adjustment, we used the same models as 
described above. In a second model, a two-way interaction 
between age and follow-up time was added to account for 
possible slope differences for cognition over time, depend-
ing on the baseline age. All SNR analyses were addition-
ally adjusted by PTA hearing thresholds. Next to the linear 
effects of hearing loss on cognition, an interaction of hearing 
loss and follow-up time was incorporated in all models, to 
allow slope differences in the relationship between cognitive 
functioning and time explained by degree of hearing loss. 
The linear hearing loss term (intercept difference) and the 
interaction term between hearing loss and follow-up time 
(slope difference) are the main terms of interest in this lon-
gitudinal analysis. For SNR analysis, random slopes were 
not included as the models failed to converge.
Third, we performed similar linear mixed models to 
study the longitudinal association between hearing levels 
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(all frequencies, speech frequencies, and SNR) and cogni-
tive trajectories per test.
In sensitivity analyses, we explored whether longitu-
dinal associations between hearing levels and cognitive 
trajectories differed between men and women and between 
mid-life (51–70 years) compared to late life (70–99 years). 
Originally, the MMSE was designed as a cognitive screen-
ing tool and is therefore limited in its capability to truly 
measure global cognitive functioning [46]. In an additional 
sensitivity analyses, we created a global cognition score, 
a g factor, by z transforming and averaging performance 
across each of the tests (except for the MMSE). Results 
were non-significant and effect estimates were smaller 
than those for the MMSE, indicating that the g factor 
in this sample cannot be considered as a more sensitive 
marker of global cognition than the MMSE. To facilitate 
interpretability and comparability (previous studies often 
used the MMSE), we chose to show the results for the 
MMSE and omit results regarding the g-factor from the 
final manuscript.
IBM SPSS Statistics version 25 (International Business 
Machines Corporation, Armonk, New York) and RStudio; 
integrated development environment for R, version 3.5.1. 
(RStudio, Boston, Massachusetts) were used for statistical 
analyses. Analyses with linear mixed models were done 
using the “lme” function of the R-package “nlme” [35]. A p 
value < 0.05 was considered statistically significant.
Results
Table 1 shows the baseline characteristics of the study 
population. Mean age was 65.2 years (SD: 7.3). 56.2% of 
our population were female. Participants had a mean all 
frequency hearing threshold of 22.8 dB (SD: 11.1). 44.6% 
of the population had normal hearing threshold levels. For 
speech understanding in noise, mean SNR was − 4.06 dB 
(SD: 4.2). Participants with a follow-up assessment com-
pared to participants with only a baseline assessment were 
significantly older, had a lower alcohol intake and were 
unhealthier (Supplementary Table 1).
Cross‑sectional results
Table 2 shows the cross-sectional association between hear-
ing loss and cognitive function. Elevated hearing thresholds 
and diminished speech in noise understanding were associ-
ated with lower scores on all cognitive tests, and appeared 
to be most pronounced for participants with severe hearing 
loss as compared to normal hearing on the Stroop test, WFT, 
LDST and the PPT (Table 2).
Longitudinal results
In the first model, mild hearing loss showed statistically 
significant intercept differences, compared to normal hear-
ing thresholds on the WFT, LDST, and the PPT (Table 3). 
In line with this, mild and moderate degrees of hearing 
loss, showed intercept differences for all cognitive tests, 
though not statistically significant (Table 3; model 1). 
Longitudinally, moderate hearing loss as compared to 
normal hearing thresholds modified the slope of memory 
functioning as measured with the 15-WLT significantly 
over time. For the other cognitive tests no significant 
slope differences were identified (Table 4; model 1). No 
significant slope differences were found for any hearing 
loss, as compared to normal speech understanding in noise 
(Table 4, model 1). The significant slope difference of the 
15-WLT became statistically non-significant, and slope 
differences of other cognitive tests became small or close 
to zero (Table 3; model 2; Fig. 1) after additional adjust-
ment for the interaction between age and follow-up time. 
Comparable results were found for degrees of hearing loss 
as measured with the DIN test (Table 4; model 2).  
Moreover, assessing hearing levels continuously 
showed that the additional change in cognitive functioning 
attributable to hearing loss were small and non-significant 
for both hearing thresholds and speech understanding in 
noise (Supplementary Table 2). Results did not differ 
between males and females or between midlife and late-
life (Supplementary Tables 3 and 4).
Discussion
In this large population-based study in non-demented older 
adults at risk for cognitive decline and cognitive impair-
ment, we found that hearing loss was associated with 
poorer global cognitive functioning, executive functioning, 
verbal fluency, attention, memory, and manual dexterity. 
After adjustment for the possible non-linear effects of age 
on cognitive change during follow-up, we did not find that 
hearing loss for either hearing thresholds or speech under-
standing in noise accelerates cognitive decline over time.
Strengths of this study are its prospective and longitu-
dinal population-based design, the large sample size and 
the standardized assessment of hearing thresholds with 
pure-tone audiometry and a speech-in-noise test as well as 
cognitive functioning with comprehensive cognitive test-
ing. However, the following limitations of this study must 
be considered. First, although we extensively adjusted for 
age and other important confounders, residual confounding 
might still be present. For example, frailty and psychosocial 
well-being may confound our results as those are known to 
be highly related to age-related hearing loss [1, 51]. Second, 
Journal of Neurology 
1 3
dementia incidence of participants with a baseline hearing 
assessment is small (N = 15), precluding the possibility to 
analyze whether hearing loss is associated with an increased 
risk of dementia in this sample.
Our cross-sectional results were comparable with other 
studies, reflected in lower scores on cognitive tests with 
higher levels of hearing loss [14, 28, 37]. It is of great inter-
est that based on our results hearing loss (both peripheral 
and central) seems to affect executive functioning, verbal 
fluency, memory, manual dexterity and to some extent 
global cognitive functioning. Previous studies have argued 
that hearing loss leads to an increased cognitive load, shift-
ing cognitive capacities towards sensory impairments rather 
than cognition [50]. Therefore, processes such as attention, 
memory, executive functioning, inhibitory control and ver-
bal fluency may be compromised as a result of hearing loss. 
Table 1  Baseline characteristics
Values are mean (standard deviation [SD]) for continuous variables or a median (interquartile range [IQR]) 
for non-normally distributed continuous variables and percentages for categorical variables. The amount of 
hearing loss is expressed in dB, i.e. a higher dB value reflects more hearing loss. Abbreviations: dB, deci-
bel; mmHg, millimetres of mercury
Baseline characteristics N = 3590
Age [years (SD)] 65.2 (7.3)
Age (range) 51.5–98.6
Female [N (%)] 2016 (56.2)
Educational level [N (%)]
 Primary 264 (7.4)
 Lower 1330 (37.0)
 Intermediate vocational 1049 (29.2)
 Higher 925 (25.8)
Alcohol  consumptiona, gram (IQR) 7.9 (1.4–19.1)
Smoking [N (%)]
 Never 1134 (33.5)
 Past 1828 (50.9)
 Current 611 (17.0)
Systolic blood pressure, mmHg (SD) 139.5 (21.0)
Diastolic blood pressure, mmHg (SD) 83.1 (11.2)
Use of blood pressure lowering medication [N (%)] 1449 (40.4)
Hearing thresholds measured with pure-tone audiometry
 All frequency hearing loss [dB (SD)] 20.8 (9.7)
 Speech frequency hearing loss [dB (SD)] 20.0 (10.7)
 Degree of hearing loss [N (%)]
  Normal (0–20 dB) 1601 (44.6)
  Mild (20–35 dB) 1456 (40.6)
  Moderate (35–50 dB) 425 (11.8)
  Severe (50 dB) 79 (2.2)
Speech understanding in noise measured with the digits-in-noise test N = 3498
 Signal-to-noise ratio [dB (SD)] − 4.06 (4.2)
 Degree of hearing loss [N (%)]
  Normal (0–20 dB) 1662 (46.3)
  Mild (20–35 dB) 837 (23.3)
  Moderate/severe (35–50 dB) 1,091 (30.4)
Cognitive abilities
 Mini-Mental State Examination  scorea (IQR) 29.0 (27.0–29.0)
 Stroop Test interference  scorea (IQR) 44.5 (37.9–54.1)
 Word Fluency Test  scorea (IQR) 23.0 (19.0–27.0)
 Letter Digit Substitution Test  scorea (IQR) 30.0 (26.0–35.0)
 Word Learning Test delayed recall  scorea (IQR) 8.0 (6.0–10.0)
 Purdue Pegboard Test sum  scorea (IQR) 36.0 (33.0–39.0)
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Moreover, cognitive decline, and especially diminished 
executive functioning, has repeatedly been linked to an 
increased risk of general frailty [38]. Even though we can-
not infer on causality in this cross-sectional analysis, it does 
shed important light on a general risk of frailty in elderly 
with hearing impairment and comorbid compromised cog-
nitive functioning. This underlines the great importance of 
investigating whether timely rehabilitative hearing treatment 
may alter or delay cognitive decline and possibly lowering 
the risk of full-blown dementia and/or general frailty [6, 51].
In our longitudinal analysis we found an accelerated 
decline in memory function (as measured with the 15-WLT) 
with moderate hearing loss, which is comparable to the 
results and effect estimates of other population-based stud-
ies [7, 30]. Unexpectedly, we did not find such an association 
for participants with severe levels of hearing loss, which 
could be explained by its relatively low prevalence (2.2%). 
Importantly, with further adjustment for confounding by age, 
the association between hearing loss and memory function 
became weaker and statistically non-significant. The preva-
lence of both hearing- and cognitive impairment increases 
substantially with age [15, 32]. Moreover, it is also impor-
tant to consider, especially in longitudinal studies with a 
wider age range that older individuals may decline faster 
on cognitive test performance between baseline and fol-
low-up measurement than their younger counterparts [36]. 
Table 2  Effect estimates of hearing loss and cognitive function based on the cross-sectional analysis
Difference: represents the difference in cognitive score per 10 dB increase in hearing acuity or the difference in cognitive score per 1 dB increase 
in speech understanding in noise or the difference in degree of hearing loss (both hearing acuity (PTA) and speech understanding (DIN)) as com-
pared to normal hearing. All frequencies: 0.25, 0.50, 1, 2, 4, and 8 kHz. Speech frequencies: 0.5, 1, 2, and 4 kHz. The amount of hearing loss is 
expressed in dB, i.e. a higher dB value reflects more hearing loss
CI confidence interval, dB decibel
a Defined by digits-in-noise score cut-offs. Adjusted for age,  age2, sex, education, alcohol consumption, smoking, diastolic and systolic blood 
pressure, and use of blood pressure lowering medication. Analyses using speech understanding were further adjusted for hearing acuity
Statistically significant effect estimates (p < 0.05) are indicated in bold
Hearing loss Mini− mental 
state examination 
score
Stroop test inter-
ference score
Word fluency test 
score
Letter digit substi-
tution test score
Word learning test 
delayed recall
Purdue pegboard 
test sum score
Difference (95% 
CI)
Difference (95% 
CI)
Difference (95% 
CI)
Difference (95% 
CI)
Difference (95% 
CI)
Difference (95% CI)
Hearing loss measured with pure-tone audiometry
Hearing thresholds per 10 dB increase
 All frequencies − 0.04 (− 0.14, 
0.06)
− 0.63 (− 1.31, 
0.04)
− 0.42 (− 0.65, − 
0.20)
− 0.38 (− 0.62, − 
0.14)
− 0.11 (− 0.23, − 
0.00)
− 0.33 (− 0.52, − 
0.14)
 Speech frequen-
cies
0.01 (− 0.09, 0.11) − 0.49 (− 1.15, 
0.18)
− 0.37 (− 0.59, − 
0.15)
− 0.27 (− 0.51, − 
0.03)
− 0.10 (− 0.21, 
0.01)
− 0.28 (− 0.47, − 
0.09)
Degree of hearing loss
 Normal 
(0–20 dB)
Reference Reference Reference Reference Reference Reference
 Mild (20–35 dB) − 0.07 (− 0.25, 
0.12)
− 0.75 (− 2.18, 
0.67)
− 1.02 (− 1.50, − 
0.55)
− 0.42 (− 0.93, 
0.09)
− 0.20 (− 0.44, 
0.03)
− 0.52 (− 0.92, − 
0.13)
 Moderate 
(35–50 dB)
− 0.10 (− 0.44, 
0.23)
− 1.84 (− 4.05, 
0.37)
− 0.77 (− 1.50, − 
0.03)
− 0.66 (− 1.45, 
0.12)
− 0.31 (− 0.68, 
0.05)
− 0.83 (− 1.45, − 
0.21)
 Severe (≥ 50 dB) − 0.98 (− 1.94, − 
0.02)
0.02 (− 4.58, 4.61) − 1.88 (− 3.40, − 
0.37)
− 1.91 (− 3.54, − 
0.28)
− 0.59 (− 1.35, 
0.16)
− 1.38 (− 2.67, − 
0.09)
Hearing loss measured with the digits-in-noise test
 Speech understanding in noise per 1 dB increase
Speech reception 
threshold
− 0.07 (− 0.10, − 
0.04)
− 0.59 (− 0.96, − 
0.23)
− 0.03 (− 0.12, 
0.05)
− 0.19 (− 0.30, − 
0.09)
− 0.07 (− 0.12, − 
0.02)
− 0.03 (− 0.06, 
0.00)
 Degree of hearing lossa
Normal (≤ − 
5.55 dB)
Reference Reference Reference Reference Reference Reference
Mild (− 5.55 to − 
3.80 dB)
− 0.14 (− 0.37, 
0.09)
− 2,08 (− 4.75, 
0.59)
− 0.80 (− 1.45, − 
0.14)
− 0.85 (− 1.59, − 
0.11)
− 0.41 (− 0.77, − 
0.05)
0.01 (− 0.19, 0.22)
Moderate/severe 
(> − 3.80 dB)
− 0.36 (− 0.64, − 
0.08)
− 6.19 (− 9.38, − 
2.99)
− 0.92 (− 1.71, − 
0.14)
− 1.56 (− 2.45, − 
0.66)
− 0.53 (− 0.96, − 
0.09)
− 0.29 (− 0.54, − 
0.04)
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Therefore, we added the interaction between baseline age 
and follow-up time into our statistical models, which seemed 
to explain most of the effects of hearing loss on memory 
function as the slope difference becomes statistically non-
significant in the second model. To our knowledge, only one 
other study incorporated non-linear effects of age in their 
statistical model [7]. Therefore, verification in future studies 
is needed to explore whether effects of hearing loss on cog-
nitive decline extend beyond ‘normal’ age-related decline 
of cognitive function.
Besides elevated hearing thresholds, speech understand-
ing in noise could contribute towards accelerated cogni-
tive decline. The ability to understand speech in noise is 
a complex process in which elements of peripheral pro-
cessing interact with more centrally located elements of 
auditory processing [25]. As such, it may be hypothesized 
that a potential association with cognitive functioning may 
even be stronger when specifically speech understanding is 
reduced. Interestingly, we found the same (non-significant) 
results between speech understanding in noise and cognitive 
decline. This may be explained by the fact that there is a high 
correlation between hearing loss based on audiometry and 
speech in noise results in our population [25].
It is also worthwhile considering whether found associa-
tions in our and previous studies might be driven by con-
founding and/or bias. The absence of an effect of hearing 
loss on cognitive decline in the current study is not explained 
by selection bias, as the sample with both a baseline- and 
a follow-up measurement were significantly older than the 
participants with just a baseline measurement. Moreover, 
it has been proposed that upstream common causes, i.e., 
inflammation, vascular pathology, and other systemic neu-
rodegenerative processes, may lead to both hearing loss 
and cognitive decline through central nervous system-wide 
functional decline, rather than that those two are directly 
related to one another [36]. As such, greater sensitivity in 
one domain could identify impairments in that domain prior 
to the other, leading to the appearance of a false direct asso-
ciation [36, 39].
We should also acknowledge that our follow-up time 
(mean = 4.4 years) may have been too short to capture a 
possible small, but significant effect of hearing loss on cog-
nition. Epidemiological evidence has shown that elevated 
blood pressure in mid-life, an established modifiable risk 
factor of dementia, increases the risk of cognitive impair-
ment 20–30 years later [23, 24, 26, 49]. In contrast, another 
study with a follow-up of 8 years did not find an association 
between hypertension and cognitive functioning [27]. The 
differences in these results suggest that the follow-up time 
would need to be longer to show a potential association of 
hearing loss with cognitive decline. Nevertheless, despite the 
relatively short follow-up time, we do find an effect of mild 
hearing loss on memory functioning in the first model which 
is both statistically significant as well as clinically relevant 
Fig. 1  Estimated cognitive function trajectories over time for different degrees of hearing loss as measured with pure-tone audiometry, with cor-
responding 95% confidence intervals: adjusted for age and sex
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[5, 7]. Would our follow-up time truly been too short to 
capture an effect of hearing loss on cognitive function, we 
would have expected non-significant results.
In conclusion, hearing loss was significantly associated 
with compromised cognitive function and with accelerated 
decline on the 15-WLT measuring memory function. Nota-
bly, the latter association seemed to be driven by non-linear 
effects of age. Future, population-based studies are needed to 
further confirm the role of hearing loss as a potential modifi-
able risk factor for cognitive decline, whilst paying attention 
to effects of age on cognition. Even though more research 
is needed to strengthen evidence between hearing loss and 
accelerated neurodegeneration, our results do underline 
the great importance to acknowledge the effects of hearing 
loss (whether it being direct or indirect) on compromised 
cognitive function and associated general frailty within the 
elderly.
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